BUDESONIDE (Budenofalk®)

Clinical Indication

Autoimmune hepatitis, Crohn's disease, ulcerative colitis

Date of classification

June 2013

Review date

June 2016

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.